Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IDXX

$1000 Invested In This Stock 20 Years Ago Would Be Worth $12,000 Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 6.71% on an annualized basis producing an average annual return of 13.47%. Currently, IDEXX Laboratories has a market capitalization of $28.24 billion.

Here's How Much $100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth Today

Here's How Much $100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 6.05% on an annualized basis producing an average annual return of 16.93%. Currently, IDEXX Laboratories has a market capitalization of $31.37 billion.

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX Laboratories (IDXX) should benefit. But the stocks of which of these two companies is a better buy now? Read on to learn our…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: IDEXX Laboratories Q1 Earnings

IDEXX Laboratories (NASDAQ:IDXX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Earnings Preview For IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that IDEXX Laboratories will report an earnings per share (EPS) of $2.26.

3 Pet Stocks to Buy and Hold in 2022

Despite rising pet care costs amid the Russia-Ukraine war and record-high inflation, the demand for pet care products remains strong. And because a significant increase in pet ownership amid the COVID-19 pandemic is expected to keep the demand high, we think it could be wise to scoop up shares of…

Take Advantage of These 5 High-Quality Stocks Down More Than 10% Year-to-Date

Skyrocketing inflation, the possibility of aggressive interest rate hikes, and increasing sanctions on Russia have been causing immense volatility in the stock market. Amid such uncertain market conditions, it could be wise to bet on high-quality stocks Cadence Design (CDNS), PTC (PTC), IDEXX Laboratories (IDXX), Mettler-Toledo (MTD), and Manhattan Associates…

inkl

Read news from The Economist, FT, and more,
with one subscription

Better Buy for 2022: Elanco Animal Health vs. IDEXX Laboratories

Better Buy for 2022: Elanco Animal Health vs. IDEXX Laboratories

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…

2 Beaten-Down Pet Stocks Worth Buying Right Now

2 Beaten-Down Pet Stocks Worth Buying Right Now

Pet ownership has skyrocketed during the COVID-19 pandemic, driving the demand for medications, pet food, and other pet-related services. So, beaten-down pet stocks Zoetis (ZTS) and IDEXX Laboratories (IDXX) could bounce back in the near term because the demand for pet-related products and services is expected to grow. So, let’s…

IDEXX Laboratories Stock Gains On Q4 Earnings Beat, Upbeat FY22 Outlook

IDEXX Laboratories Stock Gains On Q4 Earnings Beat, Upbeat FY22 Outlook

IDEXX Laboratories Inc (NASDAQ: IDXX) reported

3 Oversold Medical Equipment and Device Stocks to Scoop Up Right Now

3 Oversold Medical Equipment and Device Stocks to Scoop Up Right Now

A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks…

Organisations

IDEXX Laboratories

Elanco Animal Health

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

323,076 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play